主 办:北 京 中 医 药 大 学
ISSN 1006-2157 CN 11-3574/R

北京中医药大学学报 ›› 2021, Vol. 44 ›› Issue (3): 203-208.doi: 10.3969/j.issn.1006-2157.2021.03.002

• 专家述评 • 上一篇    下一篇

中医药防治过敏性鼻炎-哮喘综合征研究述评*

崔红生1, 吕明圣1,2, 王济3, 毕伟博1, 弓雪峰1,2   

  1. 1 北京中医药大学第三附属医院 北京 100029;
    2 北京中医药大学;
    3 北京中医药大学国家中医体质与治未病研究院
  • 收稿日期:2020-11-20 出版日期:2021-03-30 发布日期:2021-03-30
  • 作者简介:崔红生,男,博士,教授,主任医师,博士生导师,主要研究方向:中医药防治呼吸系统疾病,E-mail:hshcui@sina.com
  • 基金资助:
    *国家自然科学基金面上项目(No.81973715, No.82074390),北京市自然科学基金面上项目(No.7202110)

Evaluation of studies of prevention and treatment of combined allergic rhinitis and asthma syndrome with TCM*

Cui Hongsheng1, Lyu Mingsheng1,2, Wang Ji3, Bi Weibo1, Gong Xuefeng1,2   

  1. 1 Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China;
    2 Beijing University of Chinese Medicine, Beijing 100029, China;
    3 National Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
  • Received:2020-11-20 Online:2021-03-30 Published:2021-03-30
  • Contact: Prof. Cui Hongsheng, M.D., Chief Physician, Doctoral Supervisor. Beijing University of Chinese Medicine Third Affiliated Hospital. No. 51 Xiaoguan Street, Chaoyang District, Beijing 100029. E-mail: hshcui@sina.com
  • Supported by:
    National Natural Science Foundation of China (No. 81973715, No. 82074390), Beijing Natural Science Foundation (No. 7202110)

摘要: 过敏性鼻炎-哮喘综合征(CARAS)是典型的变态反应性疾病,也是呼吸系统的常见病及难治症,其患病率高,发病机制复杂,治疗手段有限,且易反复发作。中医药以整体辨证、综合治疗为特色,在此病临床诊治中有重要价值。本文对CARAS的病理机制、病因病机及中医药治疗研究等方面进行了文献述评,认为“特禀质”是CARAS患者的主要体质类型,伏邪干肺是其核心病机,“辨体-辨病-辨证”诊疗模式是其临床防治思路,随机对照试验及大样本真实世界研究是其未来研究方向。

关键词: 过敏性鼻炎-哮喘综合征, 病因病机, 治疗研究, 临床思路

Abstract: The combined allergic rhinitis and asthma syndrome (CARAS) is not only a typical allergic disease but a common and refractory disorder of the respiratory system with high prevalence rate and complex pathogenesis. Due to limited therapies, CARAS is prone to recurrent attacks. Traditional Chinese medicine (TCM), characterized by overall pattern differentiation and systemic therapy, has been proved to be valuable in the treatment of CARAS. Literature on CARAS was reviewed in terms of its etiology, pathogenesis, and treatment with TCM. Based on that, it is concluded that the special-diathesis constitution is the primary constitution of patients with CARAS, that latent pathogen attacks the lung is the core pathogenesis, constitution-disease-pattern differentiation is the way of diagnosis and treatment in clinical prevention and treatment, and the randomized controlled trial and large-sample real-world research would be the directions of future clinical study.

Key words: combined allergic rhinitis and asthma syndrome, etiology and pathogenesis, treatment research, clinical research idea

中图分类号: 

  • R256.1